Nasdaq IPOs

Facing record-high volatility and market uncertainty, one biotech is scheduled for the week ahead. Formed by New Enterprise Associate’s orphan drug accelerator Cydan, genetic disorder biotech Imara (IMRA) plans to raise $76 million at a fully diluted $301 million mark

Facing record-high volatility and market uncertainty, one biotech is scheduled for the week ahead. Formed by New Enterprise Associate’s orphan drug accelerator Cydan, genetic disorder biotech Imara (IMRA) plans to raise $76 million at a fully diluted $301 million mark

Facing record-high volatility and market uncertainty, one biotech is scheduled for the week ahead. Formed by New Enterprise Associate’s orphan drug accelerator Cydan, genetic disorder biotech Imara (IMRA) plans to raise $76 million at a $301 million market cap. The Bo

A billion-dollar IPO and two SPACs entered the market this past week, and four IPOs and five SPACs submitted initial filings. The VIX volatility index is still at record-high levels and the turbulent market environment shows no signs of steadying just yet. Waste giant GFL En

A billion-dollar IPO and two SPACs entered the market this past week, and four IPOs and five SPACs submitted initial filings. The VIX volatility index is still at record-high levels and the turbulent market environment shows no signs of steadying just yet. Waste giant GFL En

A billion-dollar IPO and two SPACs entered the market this past week, and four IPOs and five SPACs submitted initial filings. The VIX volatility index is still at record-high levels and the turbulent market environment shows no signs of steadying just yet. Waste giant G

CC Neuberger Principal Holdings I, a blank check company formed by CC Capital and Neuberger Berman, filed on Friday with the SEC to raise up to $300 million in an initial public offering. The New York, NY-based company plans to raise $300 million by offering 30 million units

CC Neuberger Principal Holdings I, a blank check company formed by CC Capital and Neuberger Berman, filed on Friday with the SEC to raise up to $300 million in an initial public offering. The New York, NY-based company plans to raise $300 million by offering 30 million

CC Neuberger Principal Holdings I, a blank check company formed by CC Capital and Neuberger Berman, filed on Friday with the SEC to raise up to $300 million in an initial public offering. The New York, NY-based company plans to raise $300 million by offering 30 million

Lyra Therapeutics, a Phase 2 biotech targeting ear, nose, and throat diseases, filed on Friday with the SEC to raise up to $58 million in an initial public offering. The Watertown, MA-based company was founded in 2005 and plans to list on the Nasdaq under the symbol LYRA. BofA S

Albertsons Companies, a US grocer operating under Albertsons, Safeway, and other banners, filed on Friday with the SEC to raise up to $100 million in an initial public offering. However, this is likely a placeholder for a deal we estimate could raise up to $2 billion. 

Zentalis Pharmaceuticals, a Phase 1/2 biotech developing novel small molecule therapies for various cancers, filed on Friday with the SEC to raise up to $100 million in an initial public offering. The company currently has three product candidates in Phase 1/2 trials and has rai

Albertsons Companies, a US grocer operating under Albertsons, Safeway, and other banners, filed on Friday with the SEC to raise up to $100 million in an initial public offering, though this is likely a placeholder for a deal we estimate could raise up to $2 billion. The

Ayala Pharmaceuticals, a Phase 2 biotech developing small molecule therapies for aggressive cancers, filed on Friday with the SEC to raise up to $50 million in an initial public offering.  The Rehovot, Israel-based company was founded in 2017 and booked $2 million in licensi

Ayala Pharmaceuticals, a Phase 2 biotech developing small molecule therapies for aggressive cancers, filed on Friday with the SEC to raise up to $50 million in an initial public offering.  The Rehovot, Israel-based company was founded in 2017 and booked $2 million in li

Fortress Value Acquisition, a blank check company formed by executives at Fortress Investment Group, filed on Friday with the SEC to raise up to $300 million in an initial public offering. The New York, NY-based company plans to raise $300 million by offering 30 million units at

Fortress Value Acquisition, a blank check company formed by executives at Fortress Investment Group, filed on Friday with the SEC to raise up to $300 million in an initial public offering. The New York, NY-based company plans to raise $300 million by offering 30 million units at

LifeSci Acquisition, a blank check company formed by LifeSci Capital targeting the healthcare industry, raised $60 million by offering 6 million units at $10 at a market cap of $73 million. The company originally planned to offer 5 million units. Each unit consists of one share

Flying Eagle Acquisition, the sixth blank check company formed by SPAC veteran Jeff Sagansky and former MGM CEO Harry Sloan, raised $600 million by offering 60 million units at $10 to command a market value of $725 million. Each unit consists of one whole share of common stock an

Flying Eagle Acquisition, the sixth blank check company formed by SPAC veteran Jeff Sagansky and former MGM CEO Harry Sloan, raised $600 million by offering 60 million units at $10 to command a market value of $725 million. Each unit consists of one whole share of common stock a